Artificial intelligence (AI)-enabled multimodal cardiovascular imaging holds significant promise for improving diagnostic accuracy, enhancing risk stratification, and supporting clinical decision-making. However, its translation into routine practice remains limited by multiple technical, infrastructural, and clinical barriers. This review synthesizes current challenges, including variability in image quality, alignment, and acquisition protocols; scarcity of large, annotated multimodality datasets; interoperability limitations across vendors and institutions; clinical skepticism due to limited prospective validation; and substantial development and implementation costs. Drawing from recent advances, we outline future research priorities to bridge the gap between technical feasibility and clinical utility. Key strategies include developing unified, vendor-agnostic AI models resilient to inter-institutional variability; integrating diverse data types such as genomics, wearable biosensors, and longitudinal clinical records; leveraging reinforcement learning for adaptive decision-support systems; and employing longitudinal imaging fusion for disease tracking and predictive analytics. We emphasize the need for rigorous prospective clinical trials, harmonized imaging standards, and collaborative data-sharing frameworks to ensure robust, equitable, and scalable deployment. Addressing these challenges through coordinated multidisciplinary efforts will be essential to realize the full potential of AI-driven multimodal cardiovascular imaging in advancing precision cardiovascular care.
Tran et al. (2025) studied this question.